Vanguard Group Inc Halozyme Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 13,281,714 shares of HALO stock, worth $763 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,281,714
Previous 12,895,096 3.0%
Holding current value
$763 Million
Previous $738 Million 13.93%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$42.57 - $61.09 $16.5 Million - $23.6 Million
386,618 Added 3.0%
13,281,714 $635 Million
Q3 2024

Nov 13, 2024
BUY
$51.3 - $64.42 $699,578 - $878,495
13,637 Added 0.11%
12,895,096 $738 Million
Q2 2024

Aug 13, 2024
SELL
$37.81 - $52.4 $6.34 Million - $8.79 Million
-167,794 Reduced 1.29%
12,881,459 $674 Million
Q1 2024

May 10, 2024
SELL
$33.68 - $41.95 $7.08 Million - $8.82 Million
-210,261 Reduced 1.59%
13,049,253 $531 Million
Q4 2023

Feb 14, 2024
BUY
$33.32 - $42.1 $5.09 Million - $6.44 Million
152,870 Added 1.17%
13,259,514 $490 Million
Q3 2023

Nov 14, 2023
SELL
$36.46 - $44.03 $1.08 Million - $1.3 Million
-29,621 Reduced 0.23%
13,106,644 $501 Million
Q2 2023

Aug 14, 2023
SELL
$30.28 - $38.74 $11.6 Million - $14.9 Million
-383,374 Reduced 2.84%
13,136,265 $474 Million
Q1 2023

May 15, 2023
BUY
$32.86 - $55.7 $7.09 Million - $12 Million
215,792 Added 1.62%
13,519,639 $516 Million
Q4 2022

Feb 10, 2023
SELL
$40.06 - $59.44 $1.25 Million - $1.86 Million
-31,308 Reduced 0.23%
13,303,847 $757 Million
Q3 2022

Nov 14, 2022
BUY
$38.53 - $51.78 $1.48 Million - $1.99 Million
38,342 Added 0.29%
13,335,155 $527 Million
Q2 2022

Aug 12, 2022
BUY
$37.35 - $48.3 $1.75 Million - $2.26 Million
46,893 Added 0.35%
13,296,813 $585 Million
Q1 2022

May 13, 2022
SELL
$31.97 - $41.06 $7.86 Million - $10.1 Million
-245,993 Reduced 1.82%
13,249,920 $528 Million
Q4 2021

Feb 14, 2022
SELL
$31.82 - $40.75 $4.13 Million - $5.29 Million
-129,828 Reduced 0.95%
13,495,913 $543 Million
Q3 2021

Nov 12, 2021
SELL
$38.47 - $46.42 $483,298 - $583,174
-12,563 Reduced 0.09%
13,625,741 $554 Million
Q2 2021

Aug 13, 2021
BUY
$38.84 - $51.31 $530 Million - $700 Million
13,638,304 New
13,638,304 $619 Million

Others Institutions Holding HALO

# of Institutions
546
Shares Held
124M
Call Options Held
668K
Put Options Held
259K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email